• Users Online: 48322
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision

Lim Ji Won, Na Kyeong-Ik

Year : 2011| Volume: 59| Issue : 2 | Page no: 93-96

   This article has been cited by
 
1 Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus
Alan R. Berger, Alan F. Cruess, Filiberto Altomare, Varun Chaudhary, Kevin Colleaux, Mark Greve, Amin Kherani, Efrem D. Mandelcorn, Hugh Parsons, Marc-André Rhéaume, Eric Tourville
Ophthalmologica. 2015; 234(1): 6
[Pubmed]  [Google Scholar] [DOI]
2 Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
SeulGi Yoo, JaeHui Kim, TaeGon Lee, ChulGu Kim, JongWoo Kim
Indian Journal of Ophthalmology. 2015; 63(1): 25
[Pubmed]  [Google Scholar] [DOI]
3 Meta-Analysis of the Effect of Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide in Central Retinal Vein Occlusion
Zi Ye Jin,Dan Zhu,Yong Tao,Ian Y. Wong,Jost B. Jonas
Journal of Ocular Pharmacology and Therapeutics. 2013; 29(9): 826
[Pubmed]  [Google Scholar] [DOI]
4 Intravitreal Triamcinolone Acetonide Compared With Bevacizumab for the Treatment of Patients With Macular Edema Secondary to Central Retinal Vein Occlusion
Gokcen Gokce,Gungor Sobaci,Ali Hakan Durukan,Fazil Cuneyt Erdurman
Postgraduate Medicine. 2013; 125(5): 51
[Pubmed]  [Google Scholar] [DOI]

 

Read this article